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REPORT

Telomere erosion in human pluripotent stem cells
leads to ATR-mediated mitotic catastrophe
It is well established that short telomeres activate an ATM-driven DNA damage response that leads to senescence in
terminally differentiated cells. However, technical limitations have hampered our understanding of how telomere shortening is
signaled in human stem cells. Here, we show that telomere attrition induces ssDNA accumulation (G-strand) at telomeres in
human pluripotent stem cells (hPSCs), but not in their differentiated progeny. This led to a unique role for ATR in the response
of hPSCs to telomere shortening that culminated in an extended S/G2 cell cycle phase and a longer period of mitosis, which was
associated with aneuploidy and mitotic catastrophe. Loss of p53 increased resistance to death, at the expense of increased
mitotic abnormalities in hPSCs. Taken together, our data reveal an unexpected dominant role of ATR in hPSCs, combined with
unique cell cycle abnormalities and, ultimately, consequences distinct from those observed in their isogenic differentiated
counterparts.

Introduction
Mammalian telomeres are composed of TTAGGG repeats bound
by shelterin, a protein complex that protects chromosome ends
and safeguards genome integrity (Palm and de Lange, 2008;
Shay and Wright, 2019). Telomeres shorten due to both the
“end-replication problem” and postreplicative end-processing
(Shay and Wright, 2019). While adult stem cells express telomerase, a large ribonucleoprotein complex capable of lengthening
telomeres, this expression is not sufficient to prevent telomere
shortening throughout organismal life (Shay and Wright, 2019).
The deleterious consequences of progressive telomere shortening
are exemplified in patients harboring mutations in telomerebiology genes, whose symptoms range from skin and liver abnormalities to lung fibrosis, bone marrow failure, and high cancer
rates (Armanios and Blackburn, 2012; Bertuch, 2016; Savage,
2018). Many of these symptoms are linked to stem cell dysfunction causing loss of homeostasis in highly proliferative tissues
(Armanios et al., 2009; Hao et al., 2005; Lee et al., 1998).
In differentiated cells such as fibroblasts, telomere dysfunction triggers an ataxia telangiectasia mutated (ATM)–dependent
DNA damage response (DDR) and the activation of the p53 and
pRb pathways. These pathways converge to induce senescence,
halting proliferation of genetically unstable cells (d’Adda di
Fagagna et al., 2003; Guo et al., 2007; Shay, 2016). However, it

remains unclear if telomere shortening in human stem cells
activates similar molecular pathways or leads to similar phenotypes, hampering our ability to design better treatment
strategies for telomere syndrome patients.
A significant hurdle has been a lack of suitable models to
study signaling events activated by short telomeres in human
stem cells. Here, we created human pluripotent stem cells
(hPSCs) in which expression of TERT, the reverse transcriptase
component of telomerase (Shay and Wright, 2019), can be conditionally regulated. With this system, we show that telomere
attrition induces a unique DDR in hPSCs. Telomere shortening
triggered accumulation of single-strand DNA (ssDNA; G-strand)
at telomeres in hPSCs, leading to a dominant role of ataxia telangiectasia and Rad3-related (ATR), in contrast to the predominant role played by ATM in terminally differentiated cells with
short telomeres (Herbig et al., 2004). In contrast with differentiated cells, telomere shortening led to an extended S/G2
phase and longer mitosis in hPSCs, which was associated with
aneuploidy and mitotic catastrophe, triggering p53-dependent
cell death. Our work reveals an unexpected dominant role of
ATR in hPSCs with short telomeres, combined with unique cell
cycle abnormalities and distinct consequences compared with
their isogenic differentiated progeny.
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Results and discussion

p53 and pRb are not involved in checkpoint activation in hPSCs
with short telomeres
To gain molecular insights into the response of hPSCs to telomere shortening, we ablated TP53 or TP53 and Rb1, two major
regulators of DDR in human cells (Hara et al., 1991; Shay et al.,
1991; Smogorzewska and de Lange, 2002), in iTERT hPSCs
(Fig. S2, A–C). The resulting cell lines (iTERT_TP53 KO and
iTERT_TP53/Rb1 KO) have normal karyotypes and show increased resistance to etoposide treatment (Fig. S2, D–F).
TP53 ablation increased the proliferative capacity of iTERT
hPSCs and fibroblasts growing without telomerase (Fig. S2 G).
The combined ablation of TP53 and Rb1 allowed fibroblasts to
Vessoni et al.
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bypass replicative senescence, as revealed by lack of β-gal
staining and failure to induce G1/S arrest (Fig. 1, A–C; and Fig.
S2 G), in agreement with previous literature (Davoli and de
Lange, 2012; Girardi et al., 1965; Hayashi et al., 2015). Interestingly, ablation of Rb1 had no additional effect in p53-null hPSCs
(Fig. S2, G and H), and the combined ablation of TP53 and Rb1 did
not rescue G2/M accumulation induced by telomere shortening
in these cells (Fig. 1 C), indicating that p53 and pRb do not
control checkpoint activation in hPSCs with short telomeres, in
strong contrast to their isogenic fibroblasts.
Telomere attrition prolongs S/G2 and mitosis in hPSCs, leading
to p53-mediated death
These results prompted us to better understand the fate of hPSCs
with short telomeres. We used a Fluorescent Ubiquitinationbased Cell Cycle Indicator (FUCCI) adapted from Sato et al.
(2019) to track cell cycle dynamics and the fate of individual
cells during live imaging (Fig. 2, A and B). Telomere erosion did
not alter G1 duration in iTERT hPSCs (PDL ∼159; long telomere =
4.4 ± 1.7 h; short telomere = 4.4 ± 1.9 h; Figs. 2 C and S3 A). Instead, it significantly increased the average length of S/G2 (long
telomere = 11.6 ± 2.5 h; short telomere = 13.4 ± 4.2 h; Figs. 2 C and
S3 B) and mitosis (long telomere = 1.1 ± 0.4 h; short telomere =
1.8 ± 0.9 h; Figs. 2 C and S3 C) in iTERT hPSCs. Our FUCCI
analysis also showed that longer S/G2 and mitosis were associated with an increase in hPSC death, specifically during these
phases of the cell cycle (Fig. 2, D–F), which was confirmed by
Annexin V and propidium iodide (PI) staining (Fig. 2, G and H).
To determine the consequences of the extended lifespan
conferred by p53 loss in hPSCs with short telomeres, we tracked
the behavior of these cells using FUCCI. p53 ablation significantly increased both S/G2 (long telomere = 12.3 ± 2.6 h; short
telomere = 17 ± 5.9 h) and mitosis (long telomere = 1.4 ± 0.9 h;
short telomere = 2.4 ±1.4 h) length in hPSCs with short telomeres
(Fig. 2 C; and Fig. S3, B and C). Concomitantly, p53 ablation
significantly protected hPSCs from death during S/G2 (long telomeres = 1%; short telomeres = 3.2%; Fig. 2 E), indicating that
p53 eliminates hPSCs with short telomeres during S/G2. This
increased protection against death due to p53 loss was confirmed
by flow cytometry (Fig. 2, G and H). Our results establish that
while the main role of p53 in fibroblasts with short telomeres is
to induce an irreversible arrest at G1/S, in hPSCs p53 is rewired
to regulate cell death during S/G2.
Loss of p53 exacerbates mitotic abnormalities induced by
telomere attrition in hPSCs
We next wanted to determine the consequences of telomere
shortening specifically during mitosis. We performed live
imaging using an H2B-mApple construct to track chromosomes
during mitosis and observed the appearance of various mitotic
abnormalities in iTERT hPSCs with short telomeres, including a
significant increase in slippage (mitotic exit without proper
chromosome segregation) and multinucleated cells with three to
four centrosomes (Fig. 3, A–C). We also detected a trend of increased numbers of cells finishing mitosis with micronucleus
(Fig. S3 D). These results were corroborated by immunofluorescence experiments where we detected a significant increase
Journal of Cell Biology
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HPSCs and fibroblasts adopt different fates in response to
telomere attrition
To study the effects of telomere shortening in human stem cells
and their differentiated progeny, we engineered hPSCs in which
telomerase activity could be conditionally regulated. We introduced a TRE-TIGHT-FLAG-TERT construct into the AAVS1 safe
harbor locus followed by knockout (KO) of the endogenous TERT
locus in hPSCs (Fig. S1, A and B). The resulting stem cell line
(iTERT [inducible-TERT] hPSCs) retained a normal karyotype
(Fig. S1 C) and activates telomerase in response to doxycycline
(DOX; Fig. S1 D).
iTERT hPSCs grew normally in the absence of DOX (telomerase off) for ∼140 d (population doubling level [PDL] ∼130)
without noticeable changes in proliferation (Fig. S1 E), despite
progressive telomere shortening (Fig. S1 F). After PDL ∼140,
iTERT hPSCs progressively slowed rates of population doubling,
with impaired colony formation and cell detachment (Fig. S1, E
and G). At PDL ∼159, iTERT hPSC culture was severely impaired
(Fig. S1 E). Surprisingly, senescence was not detected at this
stage, as iTERT hPSCs with short telomeres did not display
β-galactosidase (β-gal) staining (Fig. 1 A) and continued to replicate DNA (Fig. 1 B). This is in strong contrast to the fate of
isogenic fibroblasts differentiated from iTERT hPSCs, which
showed strong β-gal staining and a complete block in DNA
replication after growing in the absence of TERT (Fig. 1, A and
B), in agreement with previous studies in human primary fibroblasts (d’Adda di Fagagna et al., 2003; Herbig et al., 2004;
Jacobs and de Lange, 2004; Vaziri and Benchimol, 1996).
In addition, iTERT hPSCs with short telomeres displayed G2/M
accumulation and aneuploidy (>4n DNA; Figs. 1 C and S1 H), in
contrast to their isogenic fibroblasts, which showed a strong G1/S
arrest (Fig. 1 C). Reactivation of telomerase in iTERT hPSCs with
short telomeres reelongated telomeres and rescued proliferation
and cell cycle profile (Fig. S1, E, H, and I), confirming that these
phenotypes are due to telomere attrition. Combined, these results
show that isogenic hPSCs and fibroblasts respond differently to
telomere dysfunction. As other forms of DNA damage also fail
to induce a robust G1/S arrest in hPSCs (Jaiswal et al., 2020;
Momcilović et al., 2009), and the enforced arrest of the cell cycle
in G1 in these cells leads to differentiation (Maimets et al., 2008;
Neganova et al., 2009), it is tempting to speculate that hPSCs are
physiologically unable to undergo senescence due to their unique
cell cycle characteristics (Padgett and Santos, 2020).
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in the percentage of multipolar mitosis in iTERT hPSCs with
short telomeres (long telomere = 0.5%; short telomere = 14%;
Fig. 3, D and E). Most of these multipolar mitoses had three to
four centrosomes (Fig. 3, D and E).
The ablation of p53 significantly increased the frequency of
slippage and multinucleation in hPSCs with short telomeres
(Fig. 3, B and C). It also increased the occurrence and severity of
multipolar mitosis: >40% of mitoses in p53-null hPSCs with
short telomeres were multipolar (Fig. 3 F), with ∼15% of them
displaying five or more centrosomes (up to 30 centrosomes and
10 nuclei per cell were also detected; Fig. S3, E and F).
Although iTERT and iTERT_TP53 KO hPSCs with short telomeres displayed similar mitotic death rates (11.5% and 12.2%, respectively; Fig. 2 F), p53-null cells showed significantly more
mitotic instability (Fig. 3, B, C, E, and F). Accordingly, G-band
analysis confirmed that telomere shortening led to karyotype
abnormalities in iTERT hPSCs (long telomere = 0%; short telomere
= 45% of abnormal karyotypes), which was significantly potentiated by p53 loss (long telomere = 0%; short telomere = 80%; Figs.
3 H and S3 G; and Table S1). Combined, these data indicate that
loss of p53 increases the formation of chromosomal abnormalities
and resistance to death during aberrant mitosis in hPSCs with
short telomeres. Accordingly, we observed that ∼60% of the iTERT
Vessoni et al.
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hPSCs die during multipolar mitosis, while in iTERT_TP53 KO
hPSCs, this value is significantly lower (∼20%; Fig. 3 G).
ATR is the main driver of dysfunction induced by telomere
attrition in hPSCs
Next, we asked what connects telomere dysfunction to cell cycle/mitotic abnormalities in hPSCs. We focused on ATM and
ATR, known regulators of DDR that act upstream of p53 in the
response of fibroblasts to telomere dysfunction (Abraham, 2001;
Davoli et al., 2010). We confirmed activation of DDR in hPSCs
with short telomeres, with increased phosphorylation of CHK1
(Ser345) and CHK2 (Thr68) by flow cytometry (Fig. 4, A and B;
and Fig. S4, A and B). We then tested the impact of the ATM
inhibitor (ATMi) KU-55933 (Hickson et al., 2004) and the ATR
inhibitor (ATRi) VE-821 (Prevo et al., 2012) on G2/M accumulation, aneuploidy (>4n), multipolar mitosis, and cell proliferation in hPSCs with short telomeres (Fig. 4, C–F). The inhibition
of ATR induced a more significant rescue of these phenotypes
than ATMi in hPSCs with short telomeres (Fig. 4, C–F). This
result was unexpected, as ATM is generally considered the
dominant pathway in the response of human cells to telomere
attrition (Herbig et al., 2004). Also, ATRi was able to reduce
CHK1 and CHK2 phosphorylation to a greater extent than ATMi
Journal of Cell Biology
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Figure 1. hPSCs and fibroblasts adopt different fates in response to telomere (Tel.) attrition. (A) β-gal activity assay. (B and C) EdU incorporation
(percentage and absolute number of EdU+ cells is indicated in each image; B) and cell cycle analysis (C) performed in iTERT and iTERT_TP53/RB1 KO hPSCs and
their isogenic fibroblasts with long and short telomeres. PDL for cells with short telomeres: 149–159 (iTERT hPSCs); 205–215 (iTERT_TP53/RB1 KO hPSCs);
45–47 (iTERT fibroblasts); and 95–97 (iTERT_TP53/RB1 KO fibroblasts).
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in hPSCs with short telomeres (Fig. 4, A and B; and Fig. S4, A and
B). To investigate the involvement of CHK1 and CHK2 in more
detail, we depleted CHEK1 and/or CHEK2 (Fig. S4 C). Codepletion
of CHEK1 and CHEK2 significantly increased proliferation of
iTERT hPSCs with short telomeres (Fig. 4 G), but not of iTERT
hPSCs with long telomeres (Fig. S4 D). Our results show that
Vessoni et al.
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Figure 2. Telomere attrition prolongs S/G2 and mitosis duration in hPSCs, leading to p53-mediated cell death. (A) FUCCI system: Cells express EGFPH2B (green fluorescence to track mitotic chromosomes), TagBFP (blue fluorescence in G1), and mCherry (red fluorescence in S/G2/M). (B) Representative timelapse image of FUCCI live imaging. (C) Average duration (h) ± SEM of 100 events analyzed per phase (G1, S/G2, or M) per cell. (D–F) Illustrative images and
percentage cell death during G1, S/G2, or mitosis, respectively. At least 200 events were analyzed per cell cycle phase per cell and scored as live (able to transit
to the next cell cycle phase) or dead (died within that specific cell cycle phase). (G and H) Cell death analysis by Annexin V and PI staining. Average ± SD of
three independent experiments is shown in H. Tel., telomere. Statistical analysis: one-way ANOVA followed by Bonferroni’s test. **, P < 0.01; ***, P < 0.001.
PDLs for cells with short telomeres: 159 (iTERT hPSCs); 209 (iTERT_TP53 KO hPSCs).

CHK1 and CHK2 are both relevant in the response of hPSCs to
telomere dysfunction and demonstrate a major role of ATR in
the DDR of these cells.
As G2/M accumulation, aneuploidy, and mitotic catastrophe
were also observed in p53-null hPSCs with short telomeres (Figs.
1 and 3), we tested whether ATR acts independently of p53 to
Journal of Cell Biology
https://doi.org/10.1083/jcb.202011014
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Figure 3. Loss of p53 exacerbates mitotic abnormalities induced by telomere (Tel.) attrition in hPSCs. (A) Illustrative time-lapse images of a regular
mitosis, slippage, death during a multipolar mitosis, and a multinucleated cell undergoing multipolar mitosis in iTERT hPSCs expressing H2B-mApple.
(B) Percentage of mitotic cells undergoing slippage. (C) Percentage of multinucleated mitotic cells. (D) Immunofluorescence illustrative images of normal and
multipolar mitosis. Mitotic chromosomes are stained in green (pHistone H3Ser10), centrosomes in magenta (Aurora A), and DNA in blue (DAPI). (E and
F) Distribution of the number of Aurora A foci per mitotic cell (average ± SD) in iTERT hPSCs and iTERT_TP53 KO hPSCs, respectively, with long or short
telomeres. (G) Percentage of death during multipolar mitosis. (H) Percentage of abnormal karyotypes in iTERT and iTERT_TP53KO hPSCs with long and short
telomeres. PDLs for cells with short telomeres: 149–159 (iTERT hPSCs); 205–211 (iTERT_TP53 KO hPSCs). Statistical analysis: one-way ANOVA followed by
Bonferroni’s test. *, P < 0.05; **, P < 0.01. n = 3 independent experiments.
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induce those phenotypes. Indeed, ATR inhibition rescued all
phenotypes induced by short telomeres in hPSCs, regardless of
p53 status (Fig. S5, A–D). Additionally, as our results indicate
that ablation of p53 increases the resistance of hPSCs to death
induced by telomere attrition (Fig. 2 H), we tested if these cells
would show increased ATR activation. Accordingly, we observed
increased CHK1 phosphorylation levels in p53-null iTERT hPSCs
with short telomeres (Fig. S5 E).
Human stem cells with short telomeres accumulate ssDNA at
the telomeric G-strand
Our next step was to determine the mechanism behind the
predominant role of ATR in the response of hPSCs with short
telomeres. As ATR responds to accumulation of ssDNA coated by
replication protein A (RPA; Saldivar et al., 2017), we analyzed
chromatin-bound RPA by flow cytometry (Forment et al., 2012).
Our results indicate that telomere shortening significantly increases the fraction of hPSCs positive for chromatin-bound RPA
(Fig. 5, A and B). To explore this response further, we investigated the formation of ssDNA specifically at telomeres of hPSCs.
Using 2D gel analysis, we observed that hPSCs with short
Vessoni et al.
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telomeres have a significant increase in the relative abundance
of ssDNA at the telomeric G-strand relative to hPSCs with longer
telomeres (Fig. 5, C and D). Interestingly, this was not observed
in their isogenic fibroblast counterparts (Fig. 5, C and E), indicating that this response is specific to pluripotent cells. Digestion
of our DNA samples with Exonuclease I before running 2D gels
degraded most of the observed signal, confirming it arises from
single-stranded telomeric DNA overhang (Fig. 5 F). As shelterin
binds both double-stranded and single-stranded telomeric DNA,
we decided to test if the reduced expression of shelterin components (when compared with fibroblasts) could be a trigger for
the accumulation of unprotected ssDNA in hPSCs with short
telomeres. However, our analysis of the expression of POT1,
TPP1, and TIN2 shows that, if anything, hPSCs have higher levels
of expression of shelterin components when compared with
their differentiated progeny (Fig. S5 F). Therefore, while at this
moment our data do not provide clarity on the trigger for ssDNA
accumulation in hPSCs with short telomeres, they indicate that
the accumulation of ssDNA at telomeric overhangs provides the
molecular culprit that activates ATR in hPSCs with short telomeres. A model including our main findings is shown in Fig. 5 G.
Journal of Cell Biology
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Figure 4. A determinant role for ATR after telomere (Tel.) attrition in hPSCs. (A and B) Analysis of phosphoCHK1 (Ser345) and phosphoCHK2 (Thr68),
respectively, by flow cytometry in iTERT hPSCs with short telomeres in the presence of ATMi (10 µm) or ATRi (1 µm). Average ± SD of five independent
experiments. (C and D) Cell cycle distribution in iTERT hPSCs with short telomeres treated with ATMi or ATRi. Average ± SD of three independent experiments
are shown in C and representative images in D. (E) Multipolar mitosis analysis of iTERT hPSCs with short telomeres in the presence of ATMi or ATRi by
immunofluorescence. (F) Cell proliferation analysis in iTERT hPSCs with short telomeres in the presence of ATMi or ATRi. (G) Cell proliferation analysis in iTERT
hPSCs with short telomeres 7 d after transfection with the indicated siRNAs. In E–G, average ± SD of three independent experiments. Statistical analysis: oneway ANOVA followed by Bonferroni’s test. *, P < 0.05; **, P < 0.01; ***, P < 0.001. PDLs for iTERT hPSCs with short telomeres: 149–159.
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While most data generated to date detailing human cells’
response to genetic instability has been derived from terminally
differentiated cells, patients with reduced DNA repair capability
or reduced telomere maintenance potential commonly show
defects in stem or progenitor cells (Armanios and Blackburn,
Vessoni et al.
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Figure 5. ssDNA accumulates at telomeric G-strand (overhang) of hPSCs with short telomeres (Tel.). (A and B) Detection of chromatin-bound RPA by
flow cytometry in iTERT hPSCs. Illustrative images are shown in A, and average ± SD of three independent experiments shown in B. Statistical analysis: paired
t test; **, P < 0.01. (C–E) G-overhang detection in iTERT hPSCs and iTERT fibroblasts by 2D gel analysis. A representative image is shown in C, and quantification
of three independent experiments (average ± SD; *, P < 0.05) is shown in D and E. (D and E) PDLs for cells with short telomeres: 149–159 (iTERT hPSCs), 45–47
(iTERT fibroblasts). N.S., not significant. (F) Exonuclease I–mediated degradation of Telomeric ssDNA in iTERT hPSCs with short telomeres. Units of enzyme are
shown on top; relative indicates native/denatured signal. (G) Model: Telomere attrition in hPSCs leads to accumulation of ssDNA at telomeric overhangs and an
ATR-mediated response that results in prolonged S/G2 and mitosis, mitotic abnormalities, and death. In fibroblasts, ATM has a dominant role in the activation
of p53 upon telomere attrition and, together with p16/pRb, induces senescence.

2012; Fok et al., 2017; Munroe et al., 2020; Shukla et al.,
2020). Successful approaches to restore tissue function in
these patients must therefore derive from studies that take into
consideration the intrinsic differences between stem cells and
their differentiated progenies. In support of this theory, it has
Journal of Cell Biology
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Materials and methods
Culture of hPSCs
hPSCs were grown in mTeSRTM1 (#85850; Stemcell Technologies) with 1% penicillin-streptomycin (#15140122; Gibco), in the
presence of 5% O2, 5% CO2 at 37°C. hPSCs were grown on cell
culture plates coated with Matrigel (see below; #08-774-552;
Thermo Fisher Scientific), and medium was replaced daily. For
single-cell passaging, cells were washed once with DPBS 1X
(#14190136, Gibco) and incubated with Accutase (#07920;
Stemcell Technologies) for 5 min at 37°C, followed by dissociation by pipetting and centrifugation (1,500 rpm, 3 min). Cells
were then resuspended in mTeSR-1 with 10 µM of Y-27632
(#1293823; Peprotech) and plated at a density of 105 per well of a
six-well plate. For passaging of cells as small aggregates, cells
were washed once with DPBS 1X and incubated with ReLeSR
(#05872; Stemcell Technologies) for 30 s at room temperature,
followed by aspiration of ReLeSR and incubation of cells for an
Vessoni et al.
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additional 5 min at 37°C. Then, hPSCs were resuspended in
mTeSR1, gently dissociated into small clumps using a 5-ml pipette, and plated. For freezing, small aggregates of hPSCs were
resuspended in Bambanker (#NC9582225; Wako Chemicals),
transferred to Cryovials (Greiner Bio-One), placed in a Mr.
Frosty Freezing container (#5100-0001; Thermo Fisher Scientific), and stored at −80°C overnight. For long-term storage,
frozen cells were transferred to a liquid nitrogen container. To
coat culture plates with Matrigel: A stock bottle was thawed
overnight in an ice bucket placed inside a refrigerator. Using cold
pipettes, 5 ml of ice-cold DMEM and penicillin-streptomycin (1%
final) were mixed with the Matrigel stock, aliquoted into ice-cold
1.5-ml Eppendorf tubes (1 ml per tube), and stored at −20°C. To
coat plates, 1 aliquot was thawed overnight in an ice bucket inside a refrigerator, mixed with 14 ml of DMEM and penicillinstreptomycin (1%) to make a Matrigel use solution, and aliquoted
into refrigerated cell culture plates. These plates were immediately moved to the refrigerator and incubated for at least 6 h.
Immediately before plating hPSCs, Matrigel use solution was
transferred to another refrigerated cell culture plate, and the
coated plate incubated for 30 min at 37°C. The Matrigel use solution was reused up to eight times.
Genome editing of hPSCs
Construction of iTERT hPSCs
A Flag–human (h)TERT cDNA containing silent mutations in the
Exon 1 region (details below) was synthesized by Genewiz and
cloned into the AAVS1-SA-2A-PURO-TRE-eGFP donor plasmid
(#22074; Addgene) using the NcoI and SalI restriction enzyme
sites (AAVS1-SA-2A-PURO-TRE-FLAG-TERT donor plasmid). On
the day of transfection, a transfection mixture was prepared
by combining 100 µl Iscove’s Modified Dulbecco’s Medium
(#12440046; Gibco) with 1.5 µg AAVS1-SA-2A-PURO-TRE-FLAGTERT donor plasmid, 1.5 µg AVS1-SA-2A-NEO-CAG-RTTA3
(#60431; Addgene), 0.2 µg PGK-AAVS1-ZFN-Right (#60915;
Addgene), and 0.2 µg GK-AAVS1-ZFN-Left (#60916; Addgene;
Sim et al., 2016). Then, 3 µl X-tremeGENE 9 DNA Transfection
Reagent (#06 365 779 001; Roche) was added to this mixture (3:1
ratio), mixed by gently flicking the tube, and incubated at room
temperature for 20 min. This mixture was carefully pipetted
dropwise on one well of a six-well plate containing BJ-hiPSCs (BJ
human-induced PSCs) colonies at ∼40% confluence growing in
mTeSR-1 without antibiotics. Medium was replaced 16 h later,
and when cells reached ∼90% confluence, they were passaged (1:
6 split ratio using ReLeSR). Selection with Puromycin (0.5 µg/ml
in mTeSR-1 medium; #P8833; Sigma-Aldrich) started the next
day. Once kill control was dead (usually 2–3 d), selection with
Geneticin/Neomycin (40 µg/ml; #10131035; Life Technologies)
was started and proceeded for ∼7–10 d. A surviving clone was
expanded in regular hPSC culture medium, and correct integration of the PURO-TRE-FLAG-TERT and of the NEO-CAGRTTA3 constructs was checked by PCR, as described in detail in
Sim et al. (2016). This clone was then submitted to endogenous
hTERT KO using CRISPR/Cas9, and the resulting cell line was
named inducible hTERT, or simply iTERT, since expression of
the exogenous hTERT (hence telomerase activity) is induced by
DOX. These cells were grown in the presence of 75 ng/ml DOX
Journal of Cell Biology
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recently been demonstrated that TRF2, a shelterin component
essential for telomere protection in differentiated cells, is dispensable in mouse embryonic stem cells, which are viable in its
absence (Markiewicz-Potoczny et al., 2021; Ruis et al., 2021). Our
work adds to this concept of a stem cell–specific reaction to
telomere dysfunction and shows that hPSCs have a unique response to telomere shortening that greatly differs from fibroblasts. We describe that ATR activation is the main driver of loss
of function of hPSCs with short telomeres that show accumulation of genetic abnormalities, prolonged S/G2 and mitosis
phases of the cell cycle, and induction of death preferentially
during S/G2 and mitosis as well. We also establish that induction
of chromosomal aberrations and survival are significantly upregulated in the absence of p53 in hPSCs with short telomeres.
It is known that ATR activation can induce a G2/M checkpoint (Abraham, 2001; Liu et al., 2020) and that a prolonged G2
arrest can induce both centrosome amplification and multipolar
mitosis (Churikov et al., 2006; Dodson et al., 2004; Sato et al.,
2000). Thus, it is tempting to speculate that ATR activation in
stem cells with short telomeres prolongs the G2 phase of the cell
cycle, leading to centrosome duplication and mitotic catastrophe. Cells that avoid mitotic death become aneuploid and might
be eliminated by p53 during the upcoming S/G2 phase of the cell
cycle. In the absence of p53, aneuploid stem cells would then
proceed to additional rounds of abnormal mitosis, increasing
karyotypic abnormalities. It is therefore tempting to speculate
that death during multipolar mitosis in p53-ablated hPSCs with
short telomeres results from the mechanical disruption induced
by centrosome overduplication (Fragkos and Beard, 2011), a
possibility that needs to be tested further.
As mutations in telomerase cause significant chromosomal
aberrations, loss of tissue function, and elevated cancer predisposition (Alter et al., 2009; Dokal and Luzzatto, 1994), it will be
important to determine the role of ATR activation in the adult
stem cell compartments of patients with telomeropathies and
determine the potential of modulation of ATR, or its downstream targets, to mitigate some of the deleterious phenotypes
observed in these patients.
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TP53 and Rb1 gene KO
iTERT hPSCs were dissociated into single cells with Accutase,
and 2 × 105 cells were resuspended in a mix of P4 Primary Cell
Solution (16.4 µl) with Supplement-1 (3.6 µl; #PBP4-02250;
Lonza). 200 ng of the gRNA vector (see below) and 900 ng of the
p3s-Cas9HC vector (#43945; Addgene) were added to this mix,
immediately transferred to a 16-well Nucleocuvette, and nucleofected in a 4D Nucleofector System (Lonza) using the CA-137
program. 15 min after nucleofection, cells were gently resuspended in 100 µl mTeSR-1, transferred to a 15-ml conical
tube, and plated at low density in a six-well plate (in the presence of 10 µM Y-27632 without antibiotics). The day after, medium was replaced (without Y-27632), and cells were grown for
∼8 d, when colonies were ready to be manually picked under a
stereoscope. NGS to confirm successful KO of the target gene
and mycoplasma tests were performed by the Genome Engineering and iPSC Center. Karyotype analysis were performed by
Cell Line Genetics.
To knock out TP53, the gRNA sequence 59-TCGACGCTAGGA
TCTGACTG-NGG-39 was cloned into the vector MLM3636
(#43860; Addgene) using the BsmBI restriction site (Fok et al.,
2017). KO of RB1 was performed on iTERT_TP53 KO hPSCs using
the same methodology described above using the RB1 gRNA sequence 59-GGTGGCGGCCGTTTTTCGGG-NGG-39.
Culture of hPSC-derived fibroblasts
Fibroblasts were grown in fibroblast medium comprising
DMEM (#11995073; Gibco), 20% FBS (#100-500; GeminiBio),
and 1% penicillin-streptomycin, in the presence of 5% O2, 5% CO2
at 37°C. Fibroblasts were grown on cell culture plates coated
with gelatin 0.1% (see below), and medium was replaced every 4
days. For passaging (usually once a week), cells were washed
once with DPBS 1X and incubated with Trypsin-EDTA 0.05%
(#25300054; Gibco) for 5 min at 5% CO2 at 37°C and dissociated
by pipetting, and trypsin was neutralized with growth medium.
Cells were then centrifuged (1,500 rpm, 3 min), resuspended in
growth medium, and plated at a density of 8 × 104 cells per well
of a six-well plate. To freeze fibroblasts, single cells were resuspended in freezing medium (90% FBS and 10% DMSO),
transferred to cryovials, placed in a Mr. Frosty Freezing container, and stored at −80°C overnight. For long-term storage,
frozen vials were transferred to a liquid nitrogen container. To
coat culture plates with gelatin, a 0.1% stock solution of gelatin
(#G9391; Sigma-Aldrich) was prepared by dissolving 1 g into
Vessoni et al.
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1 liter of DPBS 1X and autoclaving, followed by filtration on a 0.2µm PES 500-ml filter unit (#569-0020; Nalgene). Solution was
stored at 4°C. An aliquot of the stock solution was added to
empty culture wells, incubated for 10 min at room temperature,
and aspirated, and cells were immediately plated.
Differentiation of hPSCs into fibroblasts
This protocol was adapted from Xu et al. (2004). hPSC cultures
that were ∼90% confluent were dissociated with ReleSR and
resuspended in differentiation medium comprising KO DMEM
(#10829018; Gibco), 1 mM L-glutamine (#25030081; Gibco),
0.1 mM β-mercaptoethanol (#ES-007; Millipore), 20% FBS, and
1% nonessential amino acids (#11140050; Gibco). Cells were
cultured in nonadherent cell culture plates for 4 d, in the presence of 5% O2, 5% CO2 at 37°C, to form embryoid bodies. Medium
was carefully replaced on day 2. Then, embryoid bodies were
plated on gelatin-coated plates in the presence of differentiation
medium and grown for an additional 9 d. Medium was replaced
4 d after plating. Then, the outgrowth culture was passaged by
incubating cells with 2 mg/ml Collagenase II (#07418; Stemcell
Technologies) in DPBS 1× for 30 min at 37°C. Cells were carefully
dissociated by pipetting, centrifuged (1,500 rpm, 3 min), resuspended in differentiation medium, and plated on gelatincoated plates at a density of 4 × 104 cells per well of a 12-well
plate. Cells were grown for 7 d (medium was replaced 4 d after
plating) before they were detached with Trypsin 0.05%, resuspended in fibroblast medium (DMEM supplemented with
20% FBS and 1% penicillin-streptomycin), plated on gelatincoated plates at a density of 8 × 104 cells per well of a six-well
plate, and grown as described in Culture of fibroblasts.
Karyotype analysis
Karyotype analysis was performed by Cell Line Genetics
(Madison, WI).
Drug treatment
Stock solutions of ATMi KU-55933 (#SML1109; Sigma-Aldrich)
and ATRi VE-821 (#SML1415; Sigma-Aldrich) were prepared by
dissolving these drugs in DMSO to a concentration of 10 mM
(ATMi) or 1 mM (ATRi) and stored as small aliquots at −80°C.
Before use, an aliquot was thawed and diluted in the culture
medium to a final concentration of 10 µM (ATMi) or 1 µM
(ATRi). Aliquots were thawed up to three times and then discarded. ATMi or ATRi was added daily to fresh hPSC medium
during inhibitor treatment.
A stock solution of etoposide (#E1383; Sigma-Aldrich) was
prepared by dissolving it in DMSO to a concentration of 300 µM
and stored as small aliquots at −80°C. Aliquots were thawed up
to three times and then discarded. Drug treatment with etoposide was performed by culturing cells with the desired drug
concentration for 24 h, followed by a recovery period of 3 d.
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during the entire hTERT KO step to ensure that telomerase activity was not lost at any moment. The gRNAs 59-CCCCAGGCG
CCGCACGAACG-NGG-39 and 59-CCACGTTCGTGCGGCGCCTGNGG-39 were used to generate a double-strand break in the endogenous hTERT gene. Importantly, the hTERT cDNA inserted
into the AAVS1 safe harbor locus is not cleaved by these gRNAs,
as it contains silent mutations on the protospacer adjacent motif
sequence sites. Nucleofection of the gRNAs, clonal expansion,
next-generation sequencing (NGS) to confirm successful KO of
the endogenous hTERT, mycoplasma testing, and karyotype
analysis were performed by the Genome Engineering and iPSC
Center of Washington University in St. Louis (WUSTL).

Cell viability using DRAQ5 and Sapphire700 staining
5 × 103 hPSCs were seeded as single cells per well of 96-well plate
(#655180; Greiner Bio-One). The next day, they were treated
with etoposide for 24 h, when medium was replaced and cells
were grown for an additional 3 d. Then, cells were washed once
Journal of Cell Biology
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PDLs
To calculate PDL, the formula PDL = X + 3.322 (log Y – log I) was
used, where X = initial PDL, I = initial cell number seeded, and
Y = number of cells at the end of the growth period.
Quantitative RT-PCR
RNA was obtained from frozen cell pellets using Trizol
(#15596018; Ambion) following the manufacturer’s instruction.
DNase treatment was performed on 4 µg isolated RNA from each
sample with the TURBO DNA-free kit (#AM1907; Ambion) for
25 min at 37°C. Approximately 0.75 µg DNase-treated RNA was
then reverse transcribed using SuperScript III reverse transcription (#18080044; Invitrogen) following the manufacturer’s
instruction. cDNA was diluted 10-fold in Nuclease-Free Water
(#AM9937; Ambion). Quantitative RT-PCR was performed on a
StepOnePlus Real-Time PCR System (#4376600; Applied BioSystems). Reaction: 3 µl diluted cDNA, 3 µl forward + reverse
primer mix (2.4 µM each in the primer mix), and 6 µl EvaGreen
2x Master Mix R (#MX-R; Lamda Biotech). Primers were designed using PrimerQuest software (IDT) and ordered from IDT.
Primer sequences used were CHEK1 forward, 59-TCTTCTGTT
GGATGAAAGGGATAA-39, and reverse 59- TGGTAAAGTACC
ACACATCTTGT-39; CHEK2 forward, 59-AAGCTAAATCATCCT
TGCATCATC-39, and reverse, 5-GCTTCTTTCAGGCGTTTATTCC39; and ACTB forward, 59-TTCCTTCCTGGGCATGGAGT-39, and
reverse, 59-AATGCCAGGGTACATGGTGG-39.
Western blotting
Protein was extracted from frozen cell pellets using NP-40
buffer (25 mM Hepes, 150 mM KCl, 1.5 mM MgCl2, 0.5% IGEPAL
CA-630, and 10% glycerol, pH 7.5, in RNase-free water) supplemented with Pierce Protease inhibitor (#A32955; Thermo
Fisher Scientific) and PhosSTOP (#04906837001; Roche) following the manufacturer’s instructions. Samples were incubated
on ice for 15 min and centrifuged at 14,000 rpm for 10 min at
4°C, and the supernatant was transferred to a clean tube placed
on ice. Protein quantification was performed using the Pierce
BCA Protein Assay Kit (#23225; Thermo Fisher Scientific) according to the manufacturer’s instruction. 20 µg of protein per
sample was resolved in a gradient polyacrylamide gel in 1× Tris/
glycine/SDS buffer (#1610732; Bio-Rad) and transferred onto
0.2-µm nitrocellulose membrane (#1620112; Bio-Rad) at 400 mA
for 1:15 h in 1× Tris/glycine/SDS buffer with 20% methanol
(#322415; Sigma-Aldrich). Membranes were blocked for 1 h in
Vessoni et al.
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blocking solution consisting either of 5% BSA (#A-420-250;
GoldBio) in TBS buffer (20 mM Tris and 150 mM NaCl in water)
or 5% nonfat milk in TBS buffer, depending on primary antibody. Primary antibody was diluted in blocking solution + 0.1%
Tween20 (#P1379; Sigma-Aldrich) and incubated with gentle
shaking overnight at 4°C. Membranes were washed four times
for 5 min with TBS-Tween buffer, and secondary antibody was
incubated in blocking solution + 0.1% Tween20 for 1 h with
gentle shaking at room temperature, protected from light.
Membranes were washed four times for 5 min with TBS-Tween
buffer and scanned on an Odyssey CLx Imager. Antibodies and
dilutions: mouse p53 (DO-1; 1:5,000, #SC-126; Santa Cruz Biotechnology); rabbit GAPDH (D16H11) XP (1:5,000, #5174), mouse
Rb (4H1; 1:2,000, #9309; Cell Signaling); mouse Flag M2 (1:5,000,
#F3165; Sigma-Aldrich); mouse TPP1 (1:1,000, #AB54685), rabbit
POT1 (1:1,000, #AB21382; Abcam); and mouse TIN2 (1:1,000,
#NB600-1522; Novus).
Telomere restriction fragment (TRF) analysis
Genomic DNA was extracted from frozen cell pellets by incubating samples on 500 µl tail lysis buffer (100 mM Tris, 5 mM
EDTA, 0.2% SDS, and 200 mM NaCl, pH 8.5, in water) supplemented with 400 µg/ml Proteinase K (#AM2546; Ambion) on a
thermocycler overnight at 55°C with shaking (500 rpm). Then,
600 µl isopropanol (#437522; Sigma-Aldrich) was added, and
samples were vigorously shaken and centrifuged (13,000 rpm,
5 min, room temperature). The supernatant was removed, and
the pellet was washed with 1 ml of 70% ethanol, centrifuged
(13,000 rpm, 5 min, room temperature), and resuspended in TE
(10 mM Tris and 1 mM EDTA, pH 8.0). 10 µg extracted DNA was
digested overnight with 30 U each RsaI (#R0167; New England
Biolabs) and HinfI (#R0155; New England Biolabs) restriction
enzymes and resolved on a 0.8% agarose gel for 16 h at 85 V in
Tris/borate/EDTA (TBE) buffer (89 mM Tris, 89 mM boric acid,
and 2 mM EDTA in water). Gel was then soaked in denaturing
solution (1.5 M NaCl and 0.5 M NaOH in water) for 45 min with
gentle shaking, briefly washed with deionized water, soaked in
neutralizing buffer (1.5 M NaCl and 1 M Tris, pH 7.4, in water)
for 1 h with gentle shaking, and transferred to a Hybond-N+
nylon membrane (#RPN303B; GE Healthcare) by capillarity for
48 h in 10× SSC buffer (1.5 mM NaCl and 150 mM sodium citrate,
pH 7.0, in water). Membrane was cross-linked with 700 J/m2
UVC on a Hoefer UVC 500 Crosslinker and hybridized with a
32
P-labeled telomere probe. To label the telomere probe with 32P,
a mix was prepared in water (final volume 20 µl) containing
10 µM of the oligonucleotide (CCCTAA)4; 10 U T4 polynucleotide
kinase (#M0201; NEB); 1× T4 polynucleotide kinase buffer
(#B0201; NEB); and 5 µl ATP γ-32P (#BLU502A250UC; PerkinElmer). The reaction was incubated at 37°C for 30 min and 95°C
for 5 min, and then put in ice. To label the telomeres with the
radioactive probe, the cross-linked membrane was preincubated
with 15 ml of Rapid-hyb buffer (#RPN1636; GE Healthcare)
placed inside a hybridization bottle (#25000-010; VWR) at 42°C
for 20 min in a hybridization oven with slow rotation. Then, the
radiolabeled probe mix was added and incubated for an additional 2 h. Membrane was washed once with 5× SSC + 0.1% SDS
for 20 min, and then washed twice with 1× SSC + 0.1% SDS at
Journal of Cell Biology
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with DPBS 1X, fixed with 4% PFA in DPBS 1X for 10 min at room
temperature, washed twice with DPBS 1X, and stored at 4°C.
Before staining, fixed samples were permeabilized with 0.1%
Triton X-100 (#X100; Sigma-Aldrich) for 15 min at room temperature, washed once with DPBS 1X, and incubated with
staining solution of DRAQ5 + Sapphire700 (prepared according
to manufacturer’s instruction) for 30 min at room temperature,
protected from light. Cells were washed three times with DPBS
1X and dried, and data were acquired on an Odyssey CLx Imager
(LI-COR Biosciences) using a focus offset of 3.0 mm. The signal
intensity of each well was analyzed using Image Studio Lite
software (LI-COR).

10 of 14

42°C in the hybridization oven at 42°C with rotation. The hybridized membrane was exposed (overnight up to 48 h) to a
Kodak BioMax MR film (#8701302; Carestream) at −80°C and
then developed.

Lentivirus generation and hPSC transduction
Lentiviruses were generated by transfecting 293T cells that were
∼80% confluent with third-generation lentivirus packaging
plasmids (pMDL [Gag/Pol], pVSVG, and pREV) together with the
transfer vector (DNA proportion was 3.97:2.58:1.39:1, respectively). Lipofectamine 2000 (#11668019; Invitrogen) was used as
transfection reagent. The DNA/Lipofectamine 2000 mix was
prepared according to the manufacturer’s instruction in OptiMEM (#31985062; Gibco). Medium was replaced 6 h after
transfection with 293T growth medium (10% FBS in DMEM).
Medium containing virus was collected 24 and 48 h after
transfection, filtered through a cellulose acetate 0.45-µm filter,
concentrated using Lenti-X Concentrator (#PT4421-2; Clontech),
resuspended in mTeSR-1, aliquoted, and frozen at −80°C using a
Mr. Frosty container. hPSCs were transduced by adding lentivirus preparation to growth medium and incubating cells for
24 h in the presence of 5% O2, 5% CO2 at 37°C. Lentivirus
packaging vectors (#VB160226-10009, #VB160226-10010, and
#VB160226-10011) were purchased from Vector Builder. The
pLV-EF1α_H2B-EGFP_TagBFP_hCdt1_mCherry_hGeminin vector was adapted from Sato et al. (2019) and synthesized by
Vector Builder. The pBOB-EF1α_H2B_mApple vector was a kind
gift from Dr. Sheila Stewart (WUSTL).
Immunofluorescence
hPSCs were grown on 12-mm Circle Microscope Cover Glass
(#22-293232; Thermo Fisher Scientific) coated with Matrigel
and fixed with 4% PFA (#28908; Thermo Fisher Scientific) in
DPBS 1X at room temperature for 10 min. Fixed cells were
washed twice with DPBS 1X, permeabilized with 0.2% Triton X100 for 10 min at room temperature and incubated for 1 h with
blocking solution (2% BSA in DPBS 1X). Samples were incubated
with primary antibodies overnight at 4°C, washed three times
with DPBS 1X, and incubated with secondary antibodies for 1 h at
room temperature, protected from light. After three washes
with DPBS 1X, the cover glass was lowered on top of a 6-µl drop
of ProLong Gold reagent (#P-36931; Life Technologies) placed on
Vessoni et al.
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DNA replication analysis by immunofluorescence
For DNA replication analysis, we used the Click-iT EdU Alexa
Fluor 488 Kit (#C10337; Life Technologies) according to the
manufacturer’s instruction. Briefly, EdU was added to the culture medium of hPSCs or fibroblasts grown on top of coverslips
to a final concentration of 10 µM EdU and incubated for 1 h in the
presence of 5% O2, 5% CO2 at 37°C. Then, cells were immediately
washed twice with DPBS 1X and fixed with PFA 4% in DPBS 1X
for 10 min at room temperature. Fixed samples were then
washed twice with 3% BSA in DPBS 1X, permeabilized with 0.2%
Triton X-100 0.2% for 20 min at room temperature, and washed
twice with 3% BSA in DPBS 1X, and the cocktail reaction (prepared according to the manufacturer’s instruction) was added to
the samples. Samples were incubated for 30 min protected from
light, and then immediately washed twice with 3% BSA in DPBS
1X. The cover glass was lowered on top of a 6-µl drop of ProLong
Gold reagent (#P-36931; Life Technologies) placed on top of a
microscope slide (#2949-75X25; Corning). Cells were imaged
4–24 h after mounting using a Leica DM6B upright digital research microscope (Leica Microsystems).
Cell cycle analysis by flow cytometry
Cell cycle analysis was performed using the Click-iT EdU Alexa
Fluor 488 Kit (#C10337; Life Technologies). EdU was added to the
culture medium of hPSCs or fibroblasts to a final concentration
of 10 µM EdU, and cells were incubated for 1 h in the presence of
5% O2, 5% CO2 at 37°C. Cells were washed twice with DPBS 1X,
dissociated into single cells using Accutase (hPSCs) or trypsin
0.05% (fibroblasts), centrifuged (1,500 rpm, 3 min), resuspended in fixing solution (PFA 2% in DPBS 1X), and incubated
at room temperature for 15 min. Then, cells were centrifuged
(3,000 rpm, 3 min from now on for all centrifugation steps in
this section), washed twice with DPBS 1X, and stored (in DPBS
1X) at 4°C for up to 2 mo. On the day of the analysis, cells were
centrifuged, resuspended in 1% BSA in DPBS 1X, incubated for
10 min at room temperature, centrifuged, resuspended in permeabilizing solution (1% BSA, 0.5% saponin [#8047-15-2; SigmaAldrich] in DPBS 1X), and incubated for 30 min. Cells were then
centrifuged and resuspended in 200 µl EdU detection solution
(prepared according to the manufacturer’s instruction) and incubated for 30 min, protected from light. Cells were then
centrifuged, washed with 3% BSA in DPBS 1X, centrifuged, and
Journal of Cell Biology
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Telomeric repeat amplification protocol (TRAP) analysis
Protein extraction and quantification were performed as described in the Western blotting topic of this section with addition of RNase OUT (#P/N 51535; Invitrogen) to a final
concentration of 40 U/ml in the NP-40 protein extraction buffer.
Telomere extension reactions were performed using 2.0, 0.5,
and 0.125 µg of protein extract per sample, and the resulting
products were amplified by PCR following a two-step TRAP
protocol from the manufacturer (TRAPeze Telomerase Detection
Kit, #S7700; Millipore). PCR products were resolved on a 9%
polyacrylamide 37:5:1 gel at 250 V for 3 h. Gel was dried on a gel
dryer (#583; Bio-Rad) at 80°C for 30 min, exposed for 15 min to a
Kodak BioMax MR film (#8701302; Carestream) at −80°C, and
developed.

top of a microscope slide (#2949-75X25; Corning). Cells were
imaged 4–24 h after mounting using a Leica DM6B upright
digital research microscope and a Leica DFC7000 T camera
(Leica Microsystems). Images were acquired using Leica Las X
Core software. The objective used was a PL APO 40×/0.95 CORR,
Apochromatic corrected objective with high numerical aperture,
FWD: 0.17 mm, CORR: 0.11.0,23 mm. Primary antibodies and
dilutions used were phospho-histone H3 (Ser10; 6G3; 1:300,
#9706) and Aurora A/AIK (1G4; 1:300, #4718). Secondary antibodies and dilutions used were: goat anti-rabbit IgG (H+L)
Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus
647 (1:1,000, #A32733), and goat anti-mouse IgG (H+L) CrossAdsorbed Secondary Antibody, Alexa Fluor 488 (1:1,000, #A11001; Thermo Fisher Scientific).
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resuspended in 1% BSA solution containing 2 µg/ml DAPI
(#62248; Thermo Fisher Scientific) in DPBS 1X. Cells were incubated for 15–30 min protected from light and immediately
analyzed in a FACS-Canto II (BD) in the Flow Cytometry &
Fluorescence Activated Cell Sorting Core of WUSTL. Cell doublets were detected and excluded based on DAPI width versus
DAPI area fluorescence signal. 10,000–20,000 events were acquired per sample.

Chromatin-bound RPA detection by flow cytometry
The assay was adapted from Forment et al. (2012). hPSCs were
dissociated with Accutase, centrifuged (1,500 rpm, 3 min), and
washed with DPBS 1X, and the pellet was gently resuspended in
ice-cold permeabilization buffer (0.1% Triton X-100 in cytoskeletal
buffer). Cells were incubated for 10 min on ice. 1 ml of 0.1% BSA in
DPBS 1X was added to the permeabilized samples and centrifuged
(2,000 rpm, 5 min). The pellet was resuspended in fixing solution
(2% PFA in DPBS 1X), incubated for 10 min at room temperature,
and washed twice with DPBS 1X. Cell permeabilization and antibody staining was performed exactly as described in Protein detection by flow cytometry. RPA antibody used was mouse RPA32/
RPA2 antibody [9H8] (#ab2175; Abcam; 1:300).
Cell death analysis by flow cytometry using PI and Annexin
V staining
The assay was performed using the FITC Annexin V Apoptosis
Detection Kit (#556547; BD) according to the manufacturer’s
Vessoni et al.
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Reverse transfection of siRNA
A 10-µM stock solution of siRNA was prepared by resuspending
the lyophilized duplexes in RNase-free 1× siRNA buffer (#B002000-UB-100; Horizon Discovery) and stored as small aliquots at −80°C. On the day of transfection, 0.34 µl Lipofectamine
RNAiMAX Transfection Reagent (#13778100; Invitrogen) was
added to 25 µl Opti-MEM (tube 1). In a separate tube (tube 2), 1.8
µl of the 10-µM stock solution of siRNA was added to 25 µl OptiMEM. After 5 min, tubes 1 and 2 were mixed and incubated for
20 min at room temperature. In the meantime, hPSCs were
dissociated into single cells using Accutase, and 5 × 104 cells were
resuspended in 450 µl mTeSR-1 medium containing 10 µM Y27632 and no antibiotics. 50 µl RNAiMAX/siRNA mix was added
to the cells (final volume = 500 µl) and plated on a well of a 24well plate. Medium was changed 24 h after reverse transfection.
siRNAs used were siGENOME Human CHEK1 (1111) siRNA–
SMARTpool, 5 nmol (#M-003255-04-0005), siGENOME Human
CHEK2 (11200) siRNA–SMARTpool, 5 nmol (#M-003256-06-0005),
and siGENOME Human Non-Targeting siRNA–SMARTpool, 5 nmol
(#D-001206-14-20), from Dharmacon.
Time-lapse imaging
Cells were grown in Matrigel-coated Chambered 1.5 Borosilicate
Cover Glass System (#155382PK; Nunc Lab-Tek II; Thermo
Fisher Scientific) in mTeSR-1 medium, and time-lapse imaging
was performed using a Yokogawa CSU-X1 spinning-disk confocal microscope on a Nikon Ti:Eclipse inverted microscope frame
(Washington University Center for Cellular Imaging) using a
20× objective and the PerfectFocus stability mechanism. The
camera used was a Hamamatsu ORCA-Fusion Gen-III sCMOS,
and acquisition software was Nikon NIS Elements AR v5.21.03.
Cells were maintained in the presence of 5% CO2 at 37°C during
entire live imaging. For mitosis analysis, 3D images from hPSCs
stably expressing H2B-mApple (lentivirus) were obtained every
4 min, for a total of 24 h; each z-stack image was created by
compiling approximately eight confocal images. At least 50
mitoses were analyzed per sample in each independent
Journal of Cell Biology
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Protein detection by flow cytometry
hPSCs were dissociated with Accutase, centrifuged (1,500 rpm,
3 min), resuspended in fixing solution (PFA 2% in DPBS 1X), and
incubated at room temperature for 10 min. Then, cells were
centrifuged (4,000 rpm, 3 min from now on for all centrifugation steps in this section), washed twice with DPBS 1X, and
stored (in DPBS 1X) at 4°C for ≤2 mo. Cells were centrifuged,
resuspended in blocking buffer (1% BSA and 0.5% saponin in
DPBS 1X), incubated for 10 min at room temperature, centrifuged, resuspended in blocking buffer containing primary antibody, and incubated overnight at 4°C. 1 ml blocking buffer was
added to each sample, centrifuged, resuspended in blocking
solution containing secondary antibody, and incubated for 1 h
protected from light. Then, 1 ml blocking buffer was added to
each sample, centrifuged, and resuspended in 0.4 ml DAPI solution (1% BSA and 2 µg/ml DAPI in DPBS 1X). Cells were incubated for 15 min at room temperature protected from light and
immediately analyzed in a FACS-Canto II (BD) in the Flow Cytometry & Fluorescence Activated Cell Sorting Core. Cell doublets were detected and excluded based on DAPI width versus
DAPI area fluorescence signal. 20,000 events were acquired per
sample. Primary antibodies and dilutions used were rabbit
phospho-Chk1 (Ser345; 133D3; 1:200, #2348) and rabbit
phospho-Chk2 (Thr68; 1:200, #2661; Cell Signaling). Secondary
antibodies and dilutions used were goat anti-rabbit IgG (H+L)
Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus
647 (1:1,000, #A32733), and goat anti-mouse IgG (H+L) CrossAdsorbed Secondary Antibody, Alexa Fluor 647 (1:1,000, # A21235; Thermo Fisher Scientific).

instruction. Detached (supernatant) and attached hPSCs (dissociated with Accutase) were combined, centrifuged (1,500 rpm,
3 min), resuspended in ice-cold DPBS 1X, counted, aliquoted (105
cells per 1.5-ml Eppendorf tube), centrifuged again, and resuspended in 100 µl of 1× binding buffer(100 mM Hepes/NaOH,
pH 7.5, containing 1.4 M NaCl and 25 mM CaCl2). 5 µl FITC
Annexin V and 5 µl PI solutions were added to each sample,
gently vortexed to mix, and incubated at room temperature for
15 min, protected from light. Then, 400 µl of 1× binding buffer
was added to each sample, and cells were immediately analyzed
in a FACS-Canto II (BD) in the Flow Cytometry & Fluorescence
Activated Cell Sorting Core. 10,000 events were acquired per
sample. Live cells are double negative; dead cells are positive for
PI or for both PI and Annexin V; cells at early stages of apoptosis
are Annexin V positive and PI negative. Cells treated with etoposide (75 nM) for 24 h were used as positive control in every
assay. Unstained cells, or etoposide-treated cells stained either
with PI or with Annexin V, were used to set up compensation
and quadrants.
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Neutral-neutral 2D gel electrophoresis and in-gel
hybridization
Neutral-neutral 2D agarose gel electrophoresis was performed
as described (Zhang et al., 2017). Briefly, 10 µg genomic DNA was
extracted (Qiagen) and digested with restriction enzymes RsaI
(NEB) and HinfI (NEB), to which Exonuclease I (NEB) was added
2 h before restriction enzyme treatment to remove 39 overhang
when appropriate. Digested genomic DNA was subjected to first
dimensional gel using 0.4% agarose gel in 1× TBE buffer and
electrophoresed at 1 V/cm for 12 h at room temperature. Sample
lanes were excised and immersed in 0.3 µg/ml ethidium bromide (Sigma-Aldrich) for 30 min and casted into 1% agarose gel
with 0.3 µg/ml ethidium bromide in 1× TBE. The secondary
dimensional gel was electrophoresed at 3 V/cm for 6 h at 4°C.
Afterward, the gel was pumped to dry using gel dryer (Bio-Rad)
and subjected to native and denatured in gel hybridization with
32
P-labeled C-probe. The gel was washed and exposed to PhosphorImager screen, which was then scanned by Storm and analyzed with Fiji.
Statistical analysis
The software GraphPad Prism was used to perform statistical
significance analysis. The number of independent experiments
analyzed, statistical tests performed, and statistical significance
are indicated in the figure legends.
Online supplemental material
Fig. S1 shows the engineering strategy and characterization of
iTERT hPSCs with long and short telomeres. Fig. S2 shows the
engineering strategy and characterization of iTERT hPSCs
lacking TP53 or TP53 and Rb1 and PDL curve of hPSCs and isogenic fibroblasts. Fig. S3 shows analysis of live imaging and
karyotype analysis of iTERT and iTERT_TP53 KO hPSCs with
short telomeres. Fig. S4 shows histograms of phosphoCHK1
(Ser345) and phosphoCHK2 (Thr68) analysis, CHEK1/CHEK2
knockdown levels, and impact on proliferation of iTERT hPSCs
with long telomeres. Fig. S5 shows multiple analysis in
iTERT_TP53 KO hPSCs with short telomeres in the presence of
ATMi or ATRi, pCHK1 analysis in iTERT vs iTERT_TP53 KO
hPSCs with short telomeres, as well as shelterin analysis by
Western blotting in isogenic iTERT hPSCs and fibroblasts. Table S1
shows G-band karyotype analysis in iTERT and iTERT_TP53 KO
hPSCs with long or short telomeres.
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Figure S1. Establishing a novel model to study telomere (Tel.) dysfunction in hPSCs. (A) Engineering iTERT hPSCs. First, TRE-Tight–regulated FLAG-TERT
cDNA and CAG-driven rTTA sequences were inserted into the AAVS1 safe harbor locus of BJ-iPSCs using zinc fingers. After clonal selection, the endogenous
TERT gene was knocked out using CRISPR/Cas9. Telomerase activity in the resulting cell (iTERT hPSC) is regulated by DOX. (B) NGS confirming the deletion of
the TERT endogenous locus. (C) Karyotype analysis of iTERT hPSCs. (D) TRAP analysis of iTERT hPSCs treated with different concentrations of DOX. Unedited
BJ-iPSCs were used as positive control. I.S., internal standard. (E) PDLs of iTERT hPSCs grown in the absence of DOX (black curve) or after telomerase reactivation (red curve). (F) Telomere length analysis by TRF in iTERT hPSCs kept with or without DOX for the indicated time. (G) Representative images of iTERT
hPSCs colonies grown in the presence of DOX (long telomeres) or at PDL 154 after DOX withdrawal (short telomeres). (H) Readdition of DOX for 12 d fully
rescued the cell cycle profile of iTERT hPSCs as detected by EdU and DAPI staining (flow cytometry). (I) Telomere length analysis by TRF in iTERT hPSCs grown
continuously with DOX (long telomeres, lane 1), with short telomeres (PDL 100, lane 2), and after readdition of DOX for 11, 18, or 30 d (lanes 3, 4, and 5,
respectively) to the culture media of the cells with short telomeres.
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Figure S2. Generation of isogenic iTERT hPSCs knocked out for TP53 (iTERT_TP53 KO) or both TP53 and RB1 (iTERT_TP53/RB1 KO). (A) DNA sequencing
analysis confirming ablation of TP53 in the indicated cell lines. (B) DNA sequencing data analysis confirming ablation of Rb1 in the indicated cell lines.
(C) Western blotting analysis of FLAG-TERT, p53, and pRb in iTERT hPSCs and their TP53 KO and TP53/Rb1 KO derivatives. GAPDH is shown as loading control.
(D and E) Karyotype analysis of iTERT_TP53 KO and iTERT_TP53/Rb1 KO hPSCs, respectively. (F) Survival analysis of iTERT hPSCs, TP53 KO, and TP53/Rb1 KO
after treatment with different concentrations of etoposide. Analysis performed by Sapphire700/DRAQ5 staining. (G) PDLs of iTERT hPSCs and fibroblasts, and
their TP53 and TP53/RB1 KO counterparts, grown in the absence of DOX. (H) TRF analysis in iTERT, iTERT_TP53 KO, and iTERT_TP53/RB1 KO hPSCs grown in the
absence of DOX for the indicated PDLs. Tel., telomere.

Vessoni et al.
Short telomeres induce ATR and death in hPSCs

Journal of Cell Biology
https://doi.org/10.1083/jcb.202011014

S3

Downloaded from http://rupress.org/jcb/article-pdf/220/6/e202011014/1413412/jcb_202011014.pdf by Washington University In St. Louis Libraries user on 17 June 2021

Figure S3. Cell cycle and mitotic abnormalities induced by telomere (Tel.) shortening in iTERT and iTERT_TP53 KO hPSCs. (A–C) Duration of G1, S/G2,
and mitosis, respectively, analyzed during live imaging using FUCCI. Each dot represents an individual cell. Average ± SEM. (D) Percentage of cells displaying at
least one micronucleus after mitosis is concluded. Graph shows average ± SD of three independent experiments. (E) Representative image of mitotic
iTERT_TP53 KO hPSC with short telomeres with multiple centrosomes; a normal mitosis (two centrosomes) is also visible in the same image (top right). Mitotic
chromosomes are positive for pHistone H3 (Ser10; green), centrosomes are positive for Aurora A (magenta), and DNA is stained with DAPI (blue). (F) Illustrative
time-lapse image of a multinucleated iTERT_TP53 KO hPSC with short telomeres undergoing mitosis; DNA is visualized via expression of an H2B-mApple fusion
protein. (G) Illustrative images of G-band karyotyping analysis in metaphase spreads of iTERT and iTERT_TP53 KO hPSCs, with long and short telomeres.
Statistics: one-way ANOVA followed by Bonferroni’s test. *, P < 0.05; **, P < 0.01; ***, P > 0.001. PDL for cells with short telomeres: 159 (iTERT hPSCs); 209
(iTERT_TP53 KO hPSCs).
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Figure S4. Analysis of the effects of ATM or ATRis or CHEK1 and/or CHEK2 silencing on iTERT hPSCs with short telomeres (Tel.). (A and B) Representative histograms of phosphorylated CHK1 (Ser 345) and phosphorylated CHK2 (Thr 68), respectively, in iTERT hPSCs with short telomeres treated with
ATMi (10 µm) or ATRi (1 µm) for four consecutive days. (C) mRNA levels of CHEK1 and CHEK2 72 h after transfection with the indicated siRNAs. Bar graphs
represent average ± SD of three biological replicates, normalized to housekeeping gene ACTB. (D) Cell proliferation analysis of iTERT hPSCs with long telomeres
7 d after transfection with the indicated siRNAs. Average ± SD of three independent experiments. PDL for iTERT hPSCs with short telomeres: 159.
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Figure S5. Analysis of the effects of ATM or ATRis on iTERT_TP53 KO hPSCs with short telomeres (Tel.), shelterin components between isogenic
iTERT hPSCs and fibroblasts. (A and B) Cell cycle distribution as detected by EdU and DAPI staining by flow cytometry in iTERT_TP53 KO hPSCs with short
telomeres in the presence of ATMi or ATRi. Representative analyses are shown in A, and quantification of three independent experiments (average ± SD) are
depicted in B. (C) Multipolar mitosis analysis in iTERT_TP53 KO hPSCs with short telomeres in the presence of ATMi or ATRi by immunofluorescence. Average ±
SD of three independent experiments. (D) Cell proliferation analysis of iTERT_TP53 KO hPSCs with short telomeres in the presence of ATMi or ATRi. (E) Analysis
of phosphorylated CHK1 (Ser 345) between iTERT and iTERT_TP53 KO hPSCs. (F) Analysis of shelterin components in isogenic iTERT hPSCs and fibroblasts.
Average ± SD of three independent experiments. Statistics: one-way ANOVA followed by Bonferroni’s test. *, P < 0.05; **, P < 0.01; ***, P < 0.001. PDL for cells
with short telomeres: 149–159 (iTERT hPSCs); 205–210 (iTERT_TP53 KO hPSCs); 45–47 (iTERT fibroblasts).

Provided online is one table. Table S1 shows karyotype analysis in iTERT and iTERT_TP53 KO hPSCs with long and short telomeres.

Vessoni et al.
Short telomeres induce ATR and death in hPSCs

Journal of Cell Biology
https://doi.org/10.1083/jcb.202011014

S6

